Who is the CEO of Theranexus SA?

The CEO of Theranexus SA is Mathieu Charvériat.

What industry does Theranexus SA belong to?

Theranexus SA operates in the Biotechnology industry within the Healthcare sector.

Where is Theranexus SA headquartered?

Theranexus SA is headquartered at 60 avenue Rockefeller, Lyon, 69008, FR.

What is the IPO date of Theranexus SA?

Theranexus SA went public on October 30, 2017.

How many employees does Theranexus SA have?

Theranexus SA has approximately 12 full-time employees.

Theranexus SA

ALTHX.PA•EURONEXT

Healthcare

Biotechnology

€1.64

€0.20(14.29%)

Theranexus SA (ALTHX.PA) Company Profile & Overview

Explore Theranexus SA’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Theranexus SA (ALTHX.PA) Company Profile & Overview

Theranexus société anonyme, a biopharmaceutical company, develops drug candidates for the treatment of central nervous system disorders. The company's lead drug candidate is THN102, which is in Phase II clinical trial to treat sleep/wake disorders. It also develops THN201 for the treatment of neurocognitive disorders linked to Alzheimer's disease; and THN101 to treat neuropathic pain. The company was founded in 2013 and is based in Lyon, France.

SectorHealthcare

IndustryBiotechnology

CEOMathieu Charvériat

Contact Information

https://www.theranexus.com

33 1 88 89 70 31

60 avenue Rockefeller, Lyon, 69008

Company Facts

12 Employees

IPO DateOct 30, 2017

CountryFR

Actively Trading

Frequently Asked Questions

;